Tony Coles's Yumanity Raises $45m To Treat Neurodegenerative Diseases

Yumanity Therapeutics has raised a $45m Series A venture capital round, which will fund continued drug discovery related to neurodegenerative diseases caused by protein misfolding, but the company's first clinical trials probably will be financed through additional financing or potential partnership agreements.